By Connor Hart
SBC Medical Group's board authorized a $20 million share repurchase program, and the Securities and Exchange Commission approved a $50 million shelf offering.
The company, which provides consulting and management services to medical corporations and clinics, said Wednesday that under its new buyback plan it may repurchase shares of its common stock through open market and privately negotiated transactions.
The timing and total amount of share repurchases will depend on factors including market conditions and regulatory requirements, and the program will expire on Dec. 31, 2026.
With SBC Medical Group's shelf offering, the company can sell portions of its $50 million stock issue without re-registering the offering or incurring penalties, allowing the company to take advantage of favorable market timing.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
December 31, 2025 07:05 ET (12:05 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.